Skip to Content
Merck
All Photos(1)

Documents

795542

Sigma-Aldrich

Graphene oxide carboxylic acid enriched

2 mg/mL, dispersion in H2O

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Linear Formula:
CxHyOz
UNSPSC Code:
12352106
NACRES:
NA.23

form

dispersion in H2O

Quality Level

100

concentration

2 mg/mL

Related Categories

Application

The carboxylic acid enriched graphene oxide can be used to fix compounds onto the GO sufrace for use in applications in biosensors; nanocomposites.

Storage Class Code

10 - Combustible liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Carboxylated graphene oxide-Mn2O3 nanorod composites for their electrochemical characteristics
Kyeong-Won Park
Journal of Material Chemistry A, 2(12), 4292-4298 (2014)
Electrochemical immunosensor based on graphene-polyaniline composites and carboxylated graphene oxide for estradiol detection
Li J, et al.
Sensors and Actuators B, Chemical, 188, 99-105 (2013)
Guangbo Qu et al.
ACS nano, 7(7), 5732-5745 (2013-06-06)
Graphene and graphene-based nanomaterials display novel and beneficial chemical, electrical, mechanical, and optical characteristics, which endow these nanomaterials with promising applications in a wide spectrum of areas such as electronics and biomedicine. However, its toxicity on health remains unknown and

Articles

Progress on Nonviral Delivery for CRISPR/Cas9

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

Progress on Nonviral Delivery for CRISPR/Cas9

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

Progress on Nonviral Delivery for CRISPR/Cas9

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

Progress on Nonviral Delivery for CRISPR/Cas9

CRISPR/Cas9 delivery via nonviral nanoparticles shows promising advancements for gene editing in disease treatment.

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service